Cargando…
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is the third leading cause of tumor-related mortality worldwide. In recent years, the emergency of immune checkpoint inhibitor (ICI) has revolutionized the management of HCC. Especially, the combination of atezolizumab (a...
Autores principales: | Chen, Chen, Wang, Zehua, Ding, Yi, Qin, Yanru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950271/ https://www.ncbi.nlm.nih.gov/pubmed/36845131 http://dx.doi.org/10.3389/fimmu.2023.1133308 |
Ejemplares similares
-
Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
por: Chen, Lu, et al.
Publicado: (2023) -
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
por: Chen, Chen, et al.
Publicado: (2022) -
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018) -
Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2021) -
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
por: DeVito, Nicholas C., et al.
Publicado: (2019)